Stocktwits on MSN
Theriva™ Biologics licenses SYN-020 to Rasayana Therapeutics for multiple indications
Theriva received a $300,000 upfront payment at signing and is eligible for up to $38M in development, regulatory, and sales ...
AUSTIN, TEXAS / ACCESS Newswire / February 24, 2026 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the Wattbike, CLMBR and ...
Shiv Kumar Padha In Hindu mythology, purity encompasses physical, mental, and spiritual cleanliness, signifying a state of ...
American clothing brand The North Face has unveiled a new concept space within Flannels to mark the launch of its SS26 Red ...
Shares of Theriva Biologics rocketed 48.6% to $0.29 yesterday, after it reported the out-licensing of SYN-020, to Rasayana Therapeutics, a privately-held company targeting the gut-organ axis biology ...
Theriva received a $300,000 upfront payment at signing and is eligible for up to $38M in development, regulatory, and sales milestones along with tiered single-digit royalties on net product sales - - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results